A Safety Study of CC-92252 in Healthy Adult Subjects and Adult Subjects With Psoriasis

NCT03971825 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

131

Enrollment

INDUSTRY

Sponsor class

Stopped Did not meet progression criteria

Conditions

Healthy Volunteers
Psoriasis

Interventions

DRUG: CC-92252
OTHER: Placebo

Sponsor

Celgene